Clinical Trial Update: Time-Effect of Montelukast Protection [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the time-dependent protective effects of Montelukast in asthma and exercise-induced bronchoconstriction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Montelukast (Montelukast)
• SINGULAIR (montelukast)

Snippet

Sponsor: Universita di Verona | Conditions: Exercise-Induced Asthma, Asthma | Phase 4 | Status: COMPLETED